IBDEI3J3 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2665,0)
 ;;=B DIAGNOSES^2^243
 ;;^UTILITY(U,$J,358.4,2666,0)
 ;;=G DIAGNOSES^7^243
 ;;^UTILITY(U,$J,358.4,2667,0)
 ;;=H DIAGNOSES^8^243
 ;;^UTILITY(U,$J,358.4,2668,0)
 ;;=L DIAGNOSES^11^243
 ;;^UTILITY(U,$J,358.4,2669,0)
 ;;=O DIAGNOSES^14^243
 ;;^UTILITY(U,$J,358.4,2670,0)
 ;;=U DIAGNOSES^19^243
 ;;^UTILITY(U,$J,358.4,2671,0)
 ;;=Z DIAGNOSES^23^243
 ;;^UTILITY(U,$J,358.4,2672,0)
 ;;=TELEHEALTH FACILITY FEE^1^244
 ;;^UTILITY(U,$J,358.4,2673,0)
 ;;=INFECTIOUS DISEASE^7^245
 ;;^UTILITY(U,$J,358.4,2674,0)
 ;;=NEOPLASMS^9^245
 ;;^UTILITY(U,$J,358.4,2675,0)
 ;;=HEMATOLOGY/ENDOCRINE^5^245
 ;;^UTILITY(U,$J,358.4,2676,0)
 ;;=MENTAL HEALTH^8^245
 ;;^UTILITY(U,$J,358.4,2677,0)
 ;;=NEUROLOGY^10^245
 ;;^UTILITY(U,$J,358.4,2678,0)
 ;;=OPHTHALMOLOGY^11^245
 ;;^UTILITY(U,$J,358.4,2679,0)
 ;;=GI^4^245
 ;;^UTILITY(U,$J,358.4,2680,0)
 ;;=CARDIOLOGY^1^245
 ;;^UTILITY(U,$J,358.4,2681,0)
 ;;=HERNIA^6^245
 ;;^UTILITY(U,$J,358.4,2682,0)
 ;;=GENITOURINARY^3^245
 ;;^UTILITY(U,$J,358.4,2683,0)
 ;;=SKIN^15^245
 ;;^UTILITY(U,$J,358.4,2684,0)
 ;;=ENT^2^245
 ;;^UTILITY(U,$J,358.4,2685,0)
 ;;=RHEUMATOLOGY/ORTHO^13^245
 ;;^UTILITY(U,$J,358.4,2686,0)
 ;;=RESPIRATORY^12^245
 ;;^UTILITY(U,$J,358.4,2687,0)
 ;;=SIGNS/SYMPTOMS/HX OF^14^245
 ;;^UTILITY(U,$J,358.4,2688,0)
 ;;=VASCULAR^16^245
 ;;^UTILITY(U,$J,358.4,2689,0)
 ;;=MD/NP/PA ^1^246
 ;;^UTILITY(U,$J,358.4,2690,0)
 ;;=RN/LPN/SW/OTH HC PROF^2^246
 ;;^UTILITY(U,$J,358.4,2691,0)
 ;;=TELEPHONE DIAGNOSES^1^247
 ;;^UTILITY(U,$J,358.4,2692,0)
 ;;=CHEST WALL AND NECK^1^248
 ;;^UTILITY(U,$J,358.4,2693,0)
 ;;=THORACIC^2^248
 ;;^UTILITY(U,$J,358.4,2694,0)
 ;;=OTHER PROCEDURES^3^248
 ;;^UTILITY(U,$J,358.4,2695,0)
 ;;=NEW PATIENT^2^249
 ;;^UTILITY(U,$J,358.4,2696,0)
 ;;=ESTABLISHED PATIENT^1^249
 ;;^UTILITY(U,$J,358.4,2697,0)
 ;;=CONSULTATIONS^3^249
 ;;^UTILITY(U,$J,358.4,2698,0)
 ;;=POST-OP FOLLOW-UP^4^249
 ;;^UTILITY(U,$J,358.4,2699,0)
 ;;=GENERAL SIGNS & SYMPTOMS^3^250
 ;;^UTILITY(U,$J,358.4,2700,0)
 ;;=AFTERCARE POST-OP^1^250
 ;;^UTILITY(U,$J,358.4,2701,0)
 ;;=POST-OP COMPLICATIONS^5^250
 ;;^UTILITY(U,$J,358.4,2702,0)
 ;;=CARDIOVASCULAR^2^250
 ;;^UTILITY(U,$J,358.4,2703,0)
 ;;=RESPIRATORY^7^250
 ;;^UTILITY(U,$J,358.4,2704,0)
 ;;=NEOPLASM^4^250
 ;;^UTILITY(U,$J,358.4,2705,0)
 ;;=PRE-OP^6^250
 ;;^UTILITY(U,$J,358.4,2706,0)
 ;;=NEW PATIENT^2^251
 ;;^UTILITY(U,$J,358.4,2707,0)
 ;;=ESTABLISHED PATIENT^1^251
 ;;^UTILITY(U,$J,358.4,2708,0)
 ;;=CONSULTATIONS^3^251
 ;;^UTILITY(U,$J,358.4,2709,0)
 ;;=POST OP VISIT (GLOBAL)^4^251
 ;;^UTILITY(U,$J,358.4,2710,0)
 ;;=BONE MARROW^1^252
 ;;^UTILITY(U,$J,358.4,2711,0)
 ;;=HEART^2^252
 ;;^UTILITY(U,$J,358.4,2712,0)
 ;;=HEART-LUNG^3^252
 ;;^UTILITY(U,$J,358.4,2713,0)
 ;;=LIVER^4^252
 ;;^UTILITY(U,$J,358.4,2714,0)
 ;;=LUNG^5^252
 ;;^UTILITY(U,$J,358.4,2715,0)
 ;;=PANCREAS^6^252
 ;;^UTILITY(U,$J,358.4,2716,0)
 ;;=RENAL^7^252
 ;;^UTILITY(U,$J,358.4,2717,0)
 ;;=REPAIR/RESECTION OF DONOR HEART^8^252
 ;;^UTILITY(U,$J,358.4,2718,0)
 ;;=CHRONIC PULM. HEART DISEASE^1^253
 ;;^UTILITY(U,$J,358.4,2719,0)
 ;;=DIS. OF BLOOD/FORMING ORGA^3^253
 ;;^UTILITY(U,$J,358.4,2720,0)
 ;;=HERNIA^5^253
 ;;^UTILITY(U,$J,358.4,2721,0)
 ;;=KIDNEY/PANCREAS^6^253
 ;;^UTILITY(U,$J,358.4,2722,0)
 ;;=LIVER^7^253
 ;;^UTILITY(U,$J,358.4,2723,0)
 ;;=LUNG^8^253
 ;;^UTILITY(U,$J,358.4,2724,0)
 ;;=MALIGNANT LYMPH & HEMATOP^9^253
 ;;^UTILITY(U,$J,358.4,2725,0)
 ;;=MALIGNANT NEOPLASMS SOLID ORGANS^10^253
 ;;^UTILITY(U,$J,358.4,2726,0)
 ;;=METABOLIC DISORDERS^11^253
 ;;^UTILITY(U,$J,358.4,2727,0)
 ;;=SYMPTOMS/SIGNS^12^253
 ;;^UTILITY(U,$J,358.4,2728,0)
 ;;=COMPLICATIONS OF SURGERY^2^253
 
--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3J3   3956     printed  Sep 23, 2025@20:25:49                                                                                                                                                                                                    Page 2
IBDEI3J3  ; ; 19-NOV-2015
 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 +2        if 'DIFQR(358.4)
               QUIT 
           FOR I=1:2
               SET X=$TEXT(Q+I)
               if X=""
                   QUIT 
               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
               SET X=$EXTRACT(X,4,999)
               if $ASCII(Y)=126
                   SET I=I+1
                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
               if $ASCII(Y)=61
                   SET Y=$EXTRACT(Y,2,999)
               XECUTE NO
              IF '$TEST
                   SET @X=Y
Q          QUIT 
 +1       ;;^UTILITY(U,$J,358.4,2665,0)
 +2       ;;=B DIAGNOSES^2^243
 +3       ;;^UTILITY(U,$J,358.4,2666,0)
 +4       ;;=G DIAGNOSES^7^243
 +5       ;;^UTILITY(U,$J,358.4,2667,0)
 +6       ;;=H DIAGNOSES^8^243
 +7       ;;^UTILITY(U,$J,358.4,2668,0)
 +8       ;;=L DIAGNOSES^11^243
 +9       ;;^UTILITY(U,$J,358.4,2669,0)
 +10      ;;=O DIAGNOSES^14^243
 +11      ;;^UTILITY(U,$J,358.4,2670,0)
 +12      ;;=U DIAGNOSES^19^243
 +13      ;;^UTILITY(U,$J,358.4,2671,0)
 +14      ;;=Z DIAGNOSES^23^243
 +15      ;;^UTILITY(U,$J,358.4,2672,0)
 +16      ;;=TELEHEALTH FACILITY FEE^1^244
 +17      ;;^UTILITY(U,$J,358.4,2673,0)
 +18      ;;=INFECTIOUS DISEASE^7^245
 +19      ;;^UTILITY(U,$J,358.4,2674,0)
 +20      ;;=NEOPLASMS^9^245
 +21      ;;^UTILITY(U,$J,358.4,2675,0)
 +22      ;;=HEMATOLOGY/ENDOCRINE^5^245
 +23      ;;^UTILITY(U,$J,358.4,2676,0)
 +24      ;;=MENTAL HEALTH^8^245
 +25      ;;^UTILITY(U,$J,358.4,2677,0)
 +26      ;;=NEUROLOGY^10^245
 +27      ;;^UTILITY(U,$J,358.4,2678,0)
 +28      ;;=OPHTHALMOLOGY^11^245
 +29      ;;^UTILITY(U,$J,358.4,2679,0)
 +30      ;;=GI^4^245
 +31      ;;^UTILITY(U,$J,358.4,2680,0)
 +32      ;;=CARDIOLOGY^1^245
 +33      ;;^UTILITY(U,$J,358.4,2681,0)
 +34      ;;=HERNIA^6^245
 +35      ;;^UTILITY(U,$J,358.4,2682,0)
 +36      ;;=GENITOURINARY^3^245
 +37      ;;^UTILITY(U,$J,358.4,2683,0)
 +38      ;;=SKIN^15^245
 +39      ;;^UTILITY(U,$J,358.4,2684,0)
 +40      ;;=ENT^2^245
 +41      ;;^UTILITY(U,$J,358.4,2685,0)
 +42      ;;=RHEUMATOLOGY/ORTHO^13^245
 +43      ;;^UTILITY(U,$J,358.4,2686,0)
 +44      ;;=RESPIRATORY^12^245
 +45      ;;^UTILITY(U,$J,358.4,2687,0)
 +46      ;;=SIGNS/SYMPTOMS/HX OF^14^245
 +47      ;;^UTILITY(U,$J,358.4,2688,0)
 +48      ;;=VASCULAR^16^245
 +49      ;;^UTILITY(U,$J,358.4,2689,0)
 +50      ;;=MD/NP/PA ^1^246
 +51      ;;^UTILITY(U,$J,358.4,2690,0)
 +52      ;;=RN/LPN/SW/OTH HC PROF^2^246
 +53      ;;^UTILITY(U,$J,358.4,2691,0)
 +54      ;;=TELEPHONE DIAGNOSES^1^247
 +55      ;;^UTILITY(U,$J,358.4,2692,0)
 +56      ;;=CHEST WALL AND NECK^1^248
 +57      ;;^UTILITY(U,$J,358.4,2693,0)
 +58      ;;=THORACIC^2^248
 +59      ;;^UTILITY(U,$J,358.4,2694,0)
 +60      ;;=OTHER PROCEDURES^3^248
 +61      ;;^UTILITY(U,$J,358.4,2695,0)
 +62      ;;=NEW PATIENT^2^249
 +63      ;;^UTILITY(U,$J,358.4,2696,0)
 +64      ;;=ESTABLISHED PATIENT^1^249
 +65      ;;^UTILITY(U,$J,358.4,2697,0)
 +66      ;;=CONSULTATIONS^3^249
 +67      ;;^UTILITY(U,$J,358.4,2698,0)
 +68      ;;=POST-OP FOLLOW-UP^4^249
 +69      ;;^UTILITY(U,$J,358.4,2699,0)
 +70      ;;=GENERAL SIGNS & SYMPTOMS^3^250
 +71      ;;^UTILITY(U,$J,358.4,2700,0)
 +72      ;;=AFTERCARE POST-OP^1^250
 +73      ;;^UTILITY(U,$J,358.4,2701,0)
 +74      ;;=POST-OP COMPLICATIONS^5^250
 +75      ;;^UTILITY(U,$J,358.4,2702,0)
 +76      ;;=CARDIOVASCULAR^2^250
 +77      ;;^UTILITY(U,$J,358.4,2703,0)
 +78      ;;=RESPIRATORY^7^250
 +79      ;;^UTILITY(U,$J,358.4,2704,0)
 +80      ;;=NEOPLASM^4^250
 +81      ;;^UTILITY(U,$J,358.4,2705,0)
 +82      ;;=PRE-OP^6^250
 +83      ;;^UTILITY(U,$J,358.4,2706,0)
 +84      ;;=NEW PATIENT^2^251
 +85      ;;^UTILITY(U,$J,358.4,2707,0)
 +86      ;;=ESTABLISHED PATIENT^1^251
 +87      ;;^UTILITY(U,$J,358.4,2708,0)
 +88      ;;=CONSULTATIONS^3^251
 +89      ;;^UTILITY(U,$J,358.4,2709,0)
 +90      ;;=POST OP VISIT (GLOBAL)^4^251
 +91      ;;^UTILITY(U,$J,358.4,2710,0)
 +92      ;;=BONE MARROW^1^252
 +93      ;;^UTILITY(U,$J,358.4,2711,0)
 +94      ;;=HEART^2^252
 +95      ;;^UTILITY(U,$J,358.4,2712,0)
 +96      ;;=HEART-LUNG^3^252
 +97      ;;^UTILITY(U,$J,358.4,2713,0)
 +98      ;;=LIVER^4^252
 +99      ;;^UTILITY(U,$J,358.4,2714,0)
 +100     ;;=LUNG^5^252
 +101     ;;^UTILITY(U,$J,358.4,2715,0)
 +102     ;;=PANCREAS^6^252
 +103     ;;^UTILITY(U,$J,358.4,2716,0)
 +104     ;;=RENAL^7^252
 +105     ;;^UTILITY(U,$J,358.4,2717,0)
 +106     ;;=REPAIR/RESECTION OF DONOR HEART^8^252
 +107     ;;^UTILITY(U,$J,358.4,2718,0)
 +108     ;;=CHRONIC PULM. HEART DISEASE^1^253
 +109     ;;^UTILITY(U,$J,358.4,2719,0)
 +110     ;;=DIS. OF BLOOD/FORMING ORGA^3^253
 +111     ;;^UTILITY(U,$J,358.4,2720,0)
 +112     ;;=HERNIA^5^253
 +113     ;;^UTILITY(U,$J,358.4,2721,0)
 +114     ;;=KIDNEY/PANCREAS^6^253
 +115     ;;^UTILITY(U,$J,358.4,2722,0)
 +116     ;;=LIVER^7^253
 +117     ;;^UTILITY(U,$J,358.4,2723,0)
 +118     ;;=LUNG^8^253
 +119     ;;^UTILITY(U,$J,358.4,2724,0)
 +120     ;;=MALIGNANT LYMPH & HEMATOP^9^253
 +121     ;;^UTILITY(U,$J,358.4,2725,0)
 +122     ;;=MALIGNANT NEOPLASMS SOLID ORGANS^10^253
 +123     ;;^UTILITY(U,$J,358.4,2726,0)
 +124     ;;=METABOLIC DISORDERS^11^253
 +125     ;;^UTILITY(U,$J,358.4,2727,0)
 +126     ;;=SYMPTOMS/SIGNS^12^253
 +127     ;;^UTILITY(U,$J,358.4,2728,0)
 +128     ;;=COMPLICATIONS OF SURGERY^2^253